Detalles de la búsqueda
1.
Patterns of biomarker expression in patients treated with primary endocrine therapy - a unique insight using core needle biopsy tissue microarray.
Breast Cancer Res Treat
; 185(3): 647-655, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33226492
2.
Expression of Lamin A/C in early-stage breast cancer and its prognostic value.
Breast Cancer Res Treat
; 174(3): 661-668, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610489
3.
Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer.
Breast Cancer Res Treat
; 158(2): 287-95, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27380874
4.
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.
Breast Cancer Res Treat
; 157(1): 65-75, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116185
5.
Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
Malays J Pathol
; 38(2): 83-92, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27568664
6.
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Br J Cancer
; 112(12): 1929-37, 2015 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25989275
7.
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
Br J Cancer
; 112(2): 283-9, 2015 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25422911
8.
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response.
Br J Cancer
; 112(5): 901-11, 2015 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25688741
9.
Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification.
Breast Cancer Res Treat
; 151(2): 325-33, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25953687
10.
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
Br J Cancer
; 110(7): 1688-97, 2014 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24619074
11.
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.
Br J Cancer
; 110(10): 2450-61, 2014 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24755885
12.
Human epidermal growth receptor-2 overexpressing early operable primary breast cancers in older (≥70 years) women: biology and clinical outcome in comparison with younger (<70 years) patients.
Ann Oncol
; 25(4): 837-842, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24667716
13.
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
Ann Oncol
; 25(8): 1536-43, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24915873
14.
A study of ductal versus non-ductal invasive breast carcinomas in older women: long-term clinical outcome and comparison with their younger counterparts.
Breast Cancer Res Treat
; 147(3): 671-4, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25148877
15.
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
Breast Cancer Res Treat
; 144(2): 331-41, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24519386
16.
Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.
Br J Cancer
; 108(5): 1042-51, 2013 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23462719
17.
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers.
Br J Cancer
; 109(7): 1886-94, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24008658
18.
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings.
Ann Oncol
; 24(11): 2801-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23908177
19.
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
Breast Cancer Res Treat
; 137(1): 127-37, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23208589
20.
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.
Ann Oncol
; 23(9): 2296-2300, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22357257